Skip to main content
logo
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.57
-1.42 (-7.48%)
At close: Nov 5, 2026, 4:00 PM EST
17.18
-0.39 (-2.22%)
After-hours: Nov 5, 2026, 7:55 PM EST

Sarepta Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-114.62-713.41235.24-535.98-703.49-418.78
Depreciation & Amortization
32.1644.5237.7244.441.8638.02
Loss (Gain) From Sale of Assets
----102--102
Loss (Gain) From Sale of Investments
-0.1412-40.28-15.86-8.084.39
Stock-Based Compensation
110.63123.4184.3182.51233.02113.94
Other Operating Activities
220.53249.9793.83407.02150.8119.43
Change in Accounts Receivable
26.56203.76-201.66-185.7-61.64-51.65
Change in Inventory
48.27-301.09-395.17-147.71-50.78-83.77
Change in Accounts Payable
-42.44104.27110.65-50.14147.5723.3
Change in Unearned Revenue
-296.6572.05-32.16-86.83-89.24-89.24
Change in Other Net Operating Assets
201.26-0.94-198.26-10.7114.62103.2
Operating Cash Flow
185.56-205.48-205.79-500.99-325.35-443.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.16-101.97-136.96-76.11-30.82-38.49
Sale (Purchase) of Intangibles
-5-7.88-1090.76-1.4399.69
Investment in Securities
-275.75179.49902.52-180.46-1,015434.21
Investing Cash Flow
-289.9169.64755.56-165.8-1,047495.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----1,127-
Long-Term Debt Repaid
--162.59-0.07--823.23-
Net Debt Issued (Repaid)
-35.13-162.59-0.07-304.17-
Issuance of Common Stock
0.5538.779.5351.2530.04569.33
Repurchase of Common Stock
--25.01----7.77
Other Financing Activities
-4.38-19.4545.3573.76-101.7-
Financing Cash Flow
-38.97-168.34124.81125232.51561.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-143.32-304.18674.58-541.79-1,140613.81

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
176.4-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Growth
------
Free Cash Flow Margin
9.02%-13.99%-18.02%-46.41%-38.17%-68.62%
Free Cash Flow Per Share
1.68-3.07-3.18-6.25-4.07-5.93
Levered Free Cash Flow
176.6495.92-432.21-330.11-54.65-8.7
Unlevered Free Cash Flow
200.47119.75-420.71-316.36-21.3731.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
14.9114.9115.8615.9244.4255.95
Cash Income Tax Paid
37.6337.6322.5915.081.70.58
Change in Working Capital
-6378.04-716.61-481.09-39.47-98.17
SEC Filings: 10-K · 10-Q